Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cancer Letters|January 23, 2017
Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancerVanita Noronha, Vijay M Patil, Amit Joshi, et al.
Indian Journal of Surgical Oncology|April 25, 2022
Systemic Therapy in Thyroid CancerAmit Kumar Agrawal, Vanita Noronha, Vijay Patil, et al.
South Asian Journal of Cancer|January 21, 2020
Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancerVanita Noronha, Nikhil Pande, Amit Joshi, et al.
Ecancermedicalscience|March 28, 2019
ROS1 mutation non-small cell lung cancer-access to optimal treatment and outcomesAmit Joshi, Nikhil Pande, Vanita Noronha, et al.
Chemotherapy Research and Practice|December 31, 2014
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC PatientsVanita Noronha, Amit Joshi, Anant Gokarn, et al.
Lung Cancer (Auckland, N.Z.)|February 19, 2019
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysisShruti Kate, Anuradha Chougule, Amit Joshi, et al.
Oncotargets and Therapy|April 14, 2017
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?Amit Joshi, Saurabh Zanwar, Vanita Noronha, et al.
Indian Journal of Cancer|August 8, 2018
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive casesSaurabh Zanwar, Vanita Noronha, Amit Joshi, et al.
Plos One|October 15, 2013
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicityAnuradha Chougule, Kumar Prabhash, Vanita Noronha, et al.
Plos One|April 27, 2013
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapyVanita Noronha, Kumar Prabhash, Abhishek Thavamani, et al.
Pageof 4